{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,11]],"date-time":"2024-05-11T00:11:53Z","timestamp":1715386313629},"reference-count":13,"publisher":"Japanese Society of Internal Medicine","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2023,2,1]]},"DOI":"10.2169\/internalmedicine.9101-21","type":"journal-article","created":{"date-parts":[[2022,7,13]],"date-time":"2022-07-13T22:11:37Z","timestamp":1657750297000},"page":"475-479","source":"Crossref","is-referenced-by-count":2,"title":["Development of Polyneuropathy, Organomegaly, Endocrinopathy, M Protein, and Skin Changes Syndrome after Conversion from Plasmacytoma of Bone to Multiple Myeloma"],"prefix":"10.2169","volume":"62","author":[{"given":"Keiko","family":"Hatano","sequence":"first","affiliation":[{"name":"Department of Neurology, Japanese Red Cross Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenta","family":"Orimo","sequence":"additional","affiliation":[{"name":"Department of Neurology, Japanese Red Cross Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mizuki","family":"Ogura","sequence":"additional","affiliation":[{"name":"Department of Hematology, Japanese Red Cross Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shingo","family":"Okabe","sequence":"additional","affiliation":[{"name":"Department of Neurology, Japanese Red Cross Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadao","family":"Ishida","sequence":"additional","affiliation":[{"name":"Department of Hematology, Japanese Red Cross Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akatsuki","family":"Kubota","sequence":"additional","affiliation":[{"name":"Department of Neurology, The University of Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Shimizu","sequence":"additional","affiliation":[{"name":"Department of Neurology, The University of Tokyo, Japan"},{"name":"Department of Physical Therapy, Faculty of Medical Health, Tokyo University of Technology, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideji","family":"Hashida","sequence":"additional","affiliation":[{"name":"Department of Neurology, Japanese Red Cross Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Bardwick PA, Zvaifler NJ, Gill GN, Newman D, Greenway GD, Resnick DL. Plasma cell dyscrasia with polyneuropathy, organomegaly, endocrinopathy, M protein, and skin changes: the POEMS syndrome. Report on two cases and a review of the literature. Medicine 59: 311-322, 1980.","DOI":"10.1097\/00005792-198007000-00006"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Miralles GD, O&apos;Fallon JR, Talley NJ. Plasma-cell dyscrasia with polyneuropathy. The spectrum of POEMS syndrome. N Engl J Med 327: 1919-1923, 1992.","DOI":"10.1056\/NEJM199212313272705"},{"key":"3","doi-asserted-by":"publisher","unstructured":"3. Suichi T, Misawa S, Beppu M, et al. Prevalence, clinical profiles, and prognosis of POEMS syndrome in Japanese nationwide survey. Neurology 93: e975-e983, 2019.","DOI":"10.1212\/WNL.0000000000008062"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Dispenzieri A. POEMS syndrome: 2019 update on diagnosis, risk-stratification, and management. Am J Hematol 94: 812-827, 2019.","DOI":"10.1002\/ajh.25495"},{"key":"5","doi-asserted-by":"publisher","unstructured":"5. Knobel D, Zouhair A, Tsang RW, et al. Prognostic factors in solitary plasmacytoma of the bone: a multicenter Rare Cancer Network study. BMC Cancer 6: 118, 2006.","DOI":"10.1186\/1471-2407-6-118"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Waal EGM, Leene M, Veeger N, et al. Progression of a solitary plasmacytoma to multiple myeloma. A population-based registry of the northern Netherlands. Br J Haematol 175: 661-667, 2016.","DOI":"10.1111\/bjh.14291"},{"key":"7","doi-asserted-by":"publisher","unstructured":"7. Egan JB, Shi CX, Tembe W, et al. Whole-genome sequencing of multiple myeloma from diagnosis to plasma cell leukemia reveals genomic initiating events, evolution, and clonal tides. Blood 120: 1060-1066, 2012.","DOI":"10.1182\/blood-2012-01-405977"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Neuse CJ, Lomas OC, Schliemann C, Shen YJ, Manier S, Bustoros M. Genome instability in multiple myeloma. Leukemia 34: 2887-2897, 2020.","DOI":"10.1038\/s41375-020-0921-y"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Isose S, Misawa S, Kanai K, et al. POEMS syndrome with Guillan-Barr\u00e9 syndrome-like acute onset: a case report and review of neurological progression in 30 cases. J Neurol Neurosurg Psychiatry 82: 678-680, 2011.","DOI":"10.1136\/jnnp.2010.205369"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Terracciano C, Fiore S, Doldo E, et al. Inverse correlation between VEGF and soluble VEGF receptor 2 in POEMS with AIDP responsive to intravenous immunoglobulin. Muscle Nerve 42: 445-448, 2010.","DOI":"10.1002\/mus.21718"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Soubrier M, Dubost JJ, Serre AF, et al. Growth factors in POEMS syndrome: evidence for a marked increase in circulating vascular endothelial growth factor. Arthritis Rheum 40: 786-787, 1997.","DOI":"10.1002\/art.1780400430"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Watanabe O, Maruyama I, Arimura K, et al. Overproduction of vascular endothelial growth factor\/vascular permeability factor is causative in Crow-Fukase (POEMS) syndrome. Muscle Nerve 21: 1390-1397, 1998.","DOI":"10.1002\/(SICI)1097-4598(199811)21:11<1390::AID-MUS5>3.0.CO;2-4"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Braun PE, Frail DE, Latov N. Myelin-associated glycoprotein is the antigen for a monoclonal IgM in polyneuropathy. J Neurochem 39: 1261-1265, 1982.","DOI":"10.1111\/j.1471-4159.1982.tb12563.x"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/62\/3\/62_9101-21\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,10]],"date-time":"2024-05-10T04:31:16Z","timestamp":1715315476000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/62\/3\/62_9101-21\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,1]]},"references-count":13,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.9101-21","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,1]]},"article-number":"9101-21"}}